logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Signaling Pathways In Cancer Pathogenesis And Therapy 1st Edition David A Frank Auth

  • SKU: BELL-2492616
Signaling Pathways In Cancer Pathogenesis And Therapy 1st Edition David A Frank Auth
$ 31.00 $ 45.00 (-31%)

5.0

18 reviews

Signaling Pathways In Cancer Pathogenesis And Therapy 1st Edition David A Frank Auth instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 2.01 MB
Pages: 148
Author: David A. Frank (auth.), David A. Frank (eds.)
ISBN: 9781461412151, 9781461412168, 1461412153, 1461412161
Language: English
Year: 2012
Edition: 1

Product desciption

Signaling Pathways In Cancer Pathogenesis And Therapy 1st Edition David A Frank Auth by David A. Frank (auth.), David A. Frank (eds.) 9781461412151, 9781461412168, 1461412153, 1461412161 instant download after payment.

In recent years, increasing evidence has suggested that abnormal activation of signaling pathways is a critical event in cancer pathogenesis. In particular, activation of these pathways can lead to inappropriate cellular survival, proliferation, pluripotency, invasion, metastasis, and angiogenesis. Thus, understanding the mechanisms by which signaling pathways become subverted in a cancer cell can provide insight into critical events in cancer pathogenesis. Furthermore, as our ability to target specific molecular interactions advances, we now have the ability to design small molecules, protein therapeutics, and other forms of targeted therapies. By focusing on the specific molecular abnormalities in a cancer cell, these agents hold the potential to be much more effective and much less toxic than current cytotoxic therapies.

Related Products